Good morning, and welcome to the Volvo Group First Quarter Press Conference. Today, we'll listen to the presentation from Martin and Mats about the first quarter results, and then we will follow up ...
If confirmed by the European Commission, REDEMPLO would be the first and only siRNA medicine authorized in the EU for both genetically confirmed and clinically diagnosed adult patients with FCS– ...
As the newly elected interim head of ORF, Ingrid Thurnher faces a difficult task: she is to clean up the chaos of the past ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results